Donor bone-marrow CXCR4+ Foxp3+ T-regulatory cells are essential for costimulation blockade-induced long-term survival of murine limb transplants.

Scientific Reports
Liqing WangWayne W Hancock

Abstract

Vascularized composite allotransplantation (VCA) allows tissue replacement after devastating loss but is currently limited in application and may be more widely performed if maintenance immunosuppression was not essential for graft acceptance. We tested whether peri-transplant costimulation blockade could prolong VCA survival and required donor bone-marrow cells, given that bone-marrow might promote graft immunogenicity or graft-versus-host disease. Peritransplant CD154 mAb/rapamycin (RPM) induced long-term orthotopic hindlimb VCA survival (BALB/c->C57BL/6), as did CTLA4Ig/RPM. Surprisingly, success of either protocol required a bone-marrow-associated, radiation-sensitive cell population, since long-bone removal or pre-transplant donor irradiation prevented long-term engraftment. Rejection also occurred if Rag1-/- donors were used, or if donors were treated with a CXCR4 inhibitor to mobilize donor BM cells pre-transplant. Donor bone-marrow contained a large population of Foxp3+ T-regulatory (Treg) cells, and donor Foxp3+ Treg depletion, by diphtheria toxin administration to DEREG donor mice whose Foxp3+ Treg cells expressed diphtheria toxin receptor, restored rejection with either protocol. Rejection also occurred if CXCR4 was ...Continue Reading

References

Mar 6, 1992·Cell·P MombaertsV E Papaioannou
May 1, 1995·The Journal of Experimental Medicine·M H SayeghL A Turka
Nov 26, 1996·Proceedings of the National Academy of Sciences of the United States of America·W W HancockL A Turka
Nov 3, 2004·The Journal of Experimental Medicine·Yuchun NieYong-Rui Zou
Apr 6, 2005·The Journal of Experimental Medicine·Iris LeeWayne W Hancock
Apr 20, 2005·The Journal of Experimental Medicine·Hal E BroxmeyerEdward F Srour
Aug 19, 2006·The Journal of Clinical Investigation·Patrick T WalshLaurence A Turka
Jan 4, 2007·The Journal of Experimental Medicine·Katharina LahlTim Sparwasser
Mar 23, 2007·Nature·Masahiro OnoShimon Sakaguchi
May 1, 2008·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·L C CendalesL Racusen
Nov 19, 2010·Expert Review of Hematology·Natalia M Moll, Richard M Ransohoff
Dec 21, 2010·Immunity·Yann M KerdilesStephen M Hedrick
Feb 4, 2012·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·J O Medina PestanaA Durrbach
Apr 20, 2012·Immunotherapy·Nina Pilat, Thomas Wekerle
Sep 22, 2012·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·T AkimovaW W Hancock
Sep 21, 2013·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·L RostaingC P Larsen
Mar 22, 2014·Annals of Surgery·Palmina PetruzzoLionel Badet
May 3, 2014·Lancet·Saami KhalifianEduardo D Rodriguez
Nov 7, 2014·Current Opinion in Organ Transplantation·Maria KoulmandaTerry B Strom
Nov 18, 2014·Plastic and Reconstructive Surgery·Jaimie T ShoresWp Andrew Lee
Jan 7, 2015·Nature Immunology·Alexandria HuynhLaurence A Turka
Nov 5, 2015·Methods in Molecular Biology·Tatiana AkimovaWayne W Hancock
Jan 10, 2019·Frontiers in Immunology·Franziska EckertStephan M Huber

❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.